This is a Validated Antibody Database (VAD) review about human COL4A3BP, based on 2 published articles (read how Labome selects the articles), using COL4A3BP antibody in all methods. It is aimed to help Labome visitors find the most suited COL4A3BP antibody. Please note the number of articles fluctuates since newly identified citations are added and citations for discontinued catalog numbers are removed regularly.
COL4A3BP synonym: CERT; CERTL; GPBP; MRD34; STARD11; collagen type IV alpha-3-binding protein; StAR-related lipid transfer (START) domain containing 11; ceramide transfer protein; ceramide transporter; collagen, type IV, alpha 3 (Goodpasture antigen) binding protein; hCERT; lipid-transfer protein CERTL

Proteintech Group
rabbit polyclonal
  • western blot; human; loading ...; fig 1b
Proteintech Group COL4A3BP antibody (Proteintech, 15191-1-AP) was used in western blot on human samples (fig 1b). J Biol Chem (2018) ncbi
Bethyl
rabbit polyclonal
  • immunoprecipitation; human; 1:1000; loading ...; fig s3b
  • immunohistochemistry; human; 1:1000; loading ...; fig 3b
  • western blot; human; 1:1000; loading ...; fig s3b
Bethyl COL4A3BP antibody (Bethyl, A300-669A) was used in immunoprecipitation on human samples at 1:1000 (fig s3b), in immunohistochemistry on human samples at 1:1000 (fig 3b) and in western blot on human samples at 1:1000 (fig s3b). Autophagy (2016) ncbi
Articles Reviewed
  1. Fukushima M, Dasgupta D, Mauer A, Kakazu E, Nakao K, Malhi H. StAR-related lipid transfer domain 11 (STARD11)-mediated ceramide transport mediates extracellular vesicle biogenesis. J Biol Chem. 2018;293:15277-15289 pubmed publisher
  2. Hernandez Tiedra S, Fabrias G, Davila D, Salanueva I, Casas J, Montes L, et al. Dihydroceramide accumulation mediates cytotoxic autophagy of cancer cells via autolysosome destabilization. Autophagy. 2016;12:2213-2229 pubmed